These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 20587492
1. The different infarct patterns between adulthood-onset and childhood-onset moyamoya disease. Cho HJ, Jung YH, Kim YD, Nam HS, Kim DS, Heo JH. J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):38-40. PubMed ID: 20587492 [Abstract] [Full Text] [Related]
2. Clinical and radiographic features of moyamoya disease in patients with both cerebral ischaemia and haemorrhage. Hishikawa T, Tokunaga K, Sugiu K, Date I. Br J Neurosurg; 2013 Apr; 27(2):198-201. PubMed ID: 22934580 [Abstract] [Full Text] [Related]
3. Infarct Pattern and Collateral Status in Adult Moyamoya Disease: A Multimodal Magnetic Resonance Imaging Study. Kim DY, Son JP, Yeon JY, Kim GM, Kim JS, Hong SC, Bang OY. Stroke; 2017 Jan; 48(1):111-116. PubMed ID: 27909201 [Abstract] [Full Text] [Related]
4. Acute Magnetic Resonance Imaging Findings in Young Children With Moyamoya Disease. Numoto S, Takasu S, Nakamura T, Takagi M, Kurahashi H, Azuma Y, Okumura A. Pediatr Neurol; 2024 Jul; 156():106-112. PubMed ID: 38749382 [Abstract] [Full Text] [Related]
5. Moyamoya disease in an extremely old patient. Chen JJ, Kung KL, Chen CJ, Tseng YC, Chen DL, Tang YM. Acta Neurol Taiwan; 2013 Dec; 22(4):158-61. PubMed ID: 24458853 [Abstract] [Full Text] [Related]
6. Clinical significance of asymmetric venous vasculature on minimum-intensity projection in patients with moyamoya disease. Han MJ, Kim SJ. Medicine (Baltimore); 2022 Oct 14; 101(41):e31067. PubMed ID: 36254048 [Abstract] [Full Text] [Related]
7. Comparison of 7.0- and 3.0-T MRI and MRA in ischemic-type moyamoya disease: preliminary experience. Deng X, Zhang Z, Zhang Y, Zhang D, Wang R, Ye X, Xu L, Wang B, Wang K, Zhao J. J Neurosurg; 2016 Jun 14; 124(6):1716-25. PubMed ID: 26544772 [Abstract] [Full Text] [Related]
8. Familial occurrence of moyamoya disease: a clinical study. Seol HJ, Wang KC, Kim SK, Hwang YS, Kim KJ, Cho BK. Childs Nerv Syst; 2006 Sep 14; 22(9):1143-8. PubMed ID: 16565850 [Abstract] [Full Text] [Related]
9. Cerebral infarction associated with moyamoya disease: histogram-based quantitative analysis of diffusion tensor imaging -- a preliminary study. Mori N, Miki Y, Fushimi Y, Kikuta K, Urayama S, Okada T, Fukuyama H, Hashimoto N, Togashi K. Magn Reson Imaging; 2008 Jul 14; 26(6):835-40. PubMed ID: 18467061 [Abstract] [Full Text] [Related]
10. Spatial relationship between cerebral microbleeds, moyamoya vessels, and hematoma in moyamoya disease. Kazumata K, Shinbo D, Ito M, Shichinohe H, Kuroda S, Nakayama N, Houkin K. J Stroke Cerebrovasc Dis; 2014 Jul 14; 23(6):1421-8. PubMed ID: 24529354 [Abstract] [Full Text] [Related]
12. Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Kim SK, Seol HJ, Cho BK, Hwang YS, Lee DS, Wang KC. Neurosurgery; 2004 Apr 14; 54(4):840-4; discussion 844-6. PubMed ID: 15046649 [Abstract] [Full Text] [Related]
13. Cerebral-perfusion-based single-photon emission computed tomography (SPECT) staging using NeuroGam® in patients with moyamoya disease. Han JH, Park YS, Lee WH, Koong SS, Min KS, Lee MS, Kim YG, Kim DH, Yi KS, Cha SH. Childs Nerv Syst; 2016 Aug 14; 32(8):1471-7. PubMed ID: 26661381 [Abstract] [Full Text] [Related]
14. Unraveling Specific Brain Microstructural Damage in Moyamoya Disease Using Diffusion Magnetic Resonance Imaging and Positron Emission Tomography. Hara S, Hori M, Ueda R, Hayashi S, Inaji M, Tanaka Y, Maehara T, Ishii K, Aoki S, Nariai T. J Stroke Cerebrovasc Dis; 2019 Apr 14; 28(4):1113-1125. PubMed ID: 30679013 [Abstract] [Full Text] [Related]
15. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China. Liu XJ, Zhang D, Wang S, Zhao YL, Teo M, Wang R, Cao Y, Ye X, Kang S, Zhao JZ. J Neurosurg; 2015 Feb 14; 122(2):392-9. PubMed ID: 25423267 [Abstract] [Full Text] [Related]
16. A novel application of four-dimensional magnetic resonance angiography using an arterial spin labeling technique for noninvasive diagnosis of Moyamoya disease. Uchino H, Ito M, Fujima N, Kazumata K, Yamazaki K, Nakayama N, Kuroda S, Houkin K. Clin Neurol Neurosurg; 2015 Oct 14; 137():105-11. PubMed ID: 26185929 [Abstract] [Full Text] [Related]
19. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, Shimojima K, Yamamoto T, Higurashi M, Kawahara N, Kawauchi H, Nagasaka K, Okamoto N, Mori T, Koyano S, Kuroiwa Y, Taguri M, Morita S, Matsubara Y, Kure S, Matsumoto N. Neurology; 2012 Mar 13; 78(11):803-10. PubMed ID: 22377813 [Abstract] [Full Text] [Related]
20. Patterns of cerebral ischemia in children with moyamoya. Rafay MF, Armstrong D, Dirks P, MacGregor DL, deVeber G. Pediatr Neurol; 2015 Jan 13; 52(1):65-72. PubMed ID: 25459363 [Abstract] [Full Text] [Related] Page: [Next] [New Search]